Facebook
X
LinkedIn
ForwardInaugural Center for Cardiovascular Disease Prevention Symposium: Innovating Prevention- From Precision Science to Real World Impact
This inaugural symposium highlights a comprehensive and multidisciplinary approach to cardiovascular disease (CVD) prevention across the lifespan. The program integrates precision science, clinical implementation, community engagement, and innovation to address major drivers of cardiovascular morbidity and mortality. Through keynote lectures, pathway-focused scientific sessions, case-based learning, panel discussions, and innovation showcases, attendees will explore prevention strategies in atherosclerosis, arrhythmias and sudden cardiac death, heart failure and cardiomyopathy, social determinants of health, women’s cardiovascular health, and cardio-oncology. The symposium also highlights emerging technologies including artificial intelligence, advanced imaging, wearable devices, omics-based risk prediction, and novel therapeutics.
Target Audience
Nurse
Nurse Practitioner
Pharmacist
Physician
Physician Assistant
Learning Objectives
By the end of this symposium, participants will be able to:
1. Apply evidence-based prevention strategies across the cardiovascular disease spectrum, including atherosclerosis, arrhythmias, sudden cardiac death, heart failure, and cardiomyopathy.
2. Incorporate precision medicine approaches including advanced imaging, multi-omics and biomarkers -to improve cardiovascular risk assessment and early disease detection.
3. Evaluate and integrate emerging technologies, such as artificial intelligence, digital health tools, and EHR-based strategies, into prevention-focused clinical care.
4. Implement multidisciplinary, lifespan-based prevention strategies to reduce the risk of initial cardiovascular events and prevent progression or recurrence.
5. Address social determinants of health by incorporating community partnerships and population health strategies to improve access, equity, and long-term outcomes.
6. Recognize and manage special population risks, including sex-specific and pregnancy-related factors, inherited conditions, and treatment-related cardiovascular complications
7. Translate innovation into practice by identifying barriers and implementing scalable, sustainable cardiovascular prevention programs.
Course summary
- 4.50 AAPA Category I CME
- 4.50 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 4.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 4.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 4.50 Attendance
Conflict of Interest Disclosure:
All individuals in a position to control the content of this educational activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients. All the relevant financial relationships for the individuals listed below have been mitigated.
Christie Ballantyne, MD: Consultant: 89Bio, Abbott Diagnostics, Amgen, Arrowhead, Astra Zeneca, Denka Seiken, Esperion, Genentech, HeartFlow, Ionis, Eli Lilly, Merck, New Amsterdam, Novartis, Novo Nordisk, Roche Diagnostic; Grant/ Research Support: Abbott Diagnostic, Akcea, Amgen, Arrowhead, Ionis, Eli Lilly, Merck, New Amsterdam, Novartis, Novo Nordisk, Roche Diagnostic, NIH, AHA, ADA
Marcio Bittencourt MD, PhD, MPH: Grant/ Research Support: Cleerly
Stephen Chan, MD, PhD, FAHA: Consultant: Merck, Janssen, United Therapeutics; Grant/ Research Support: National Institutes of Health, American Heart Assoc. and WoodNext Foundation; Other: Director, Officer, and Shareholder in Synhale Therapeutics and Amlysion Therapeutics
Tanmay Gokhale, MD, PhD: Clinical Fellowship Support: Boston Scientific, Medtronic, Abbott
Gavin Hickey, MD: Consultant: Abiomed/J&J
Sandeep Jain, MD: Consultant: Abbott Grant/ Research Support: Boston Scientific, Medtronic, Abbott
Erin Kershaw, MD: Consultant: Nodthera, Sparrow, vTv Therapeutics; Grant/ Research Support: Arrowhead Pharmaceuticals, Eli Lilly
Oscar Lopez, MD, FAAN: Consultant: Genentech; Other: Acumen: DSMB
Indu Poornima, MD, MS, FACC: Grant/ Research Support: Lilly, Amgen, Novartis
Samir Saba, MD, FACC, FHRS: Consultant: Boston Scientific, Medtronic, Abbott, Recor. Grant/ Research Support: Abbott, Boston Scientific
Anum Saeed, MD: Grant/ Research Support: American Heart Association, National Institute of Health
Prem Soman, MD, PhD, FACC, FRCP: Consultant: Pfizer, Bridgbio, Astra Zeneca, Alnylam
Harriette Van Spall, MD: CE Speakers Bureau: Bayer, Medtronic; Consultant: Novo Nordisk; Grant/ Research Support: Canadian Institutes of Health Research; Other: Baim, Bayer, CardioVascular Research Foundation, Colorado Prevention Center, Novo Nordisk, Pfizer, Medtronic – Clinical Trial Committee
No other members of the planning committee, speakers’, presenters, authors, content reviewers and/or anyone else in a position to control the content of this educational activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 4.50 contact hours.
Pharmacy (CPE)
This knowledge-based activity provides 4.50 contact hours of continuing pharmacy education credit.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other Healthcare Professionals: Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 4.50 AAPA Category I CME
- 4.50 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 4.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 4.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 4.50 Attendance
Alnylam Pharmaceuticals
Amgen
Arrowhead Pharmaceuticals, Inc.
Astrazeneca Pharmaceuticals
Boehringer Ingelheim
Heartflow
Ionis Pharmaceuticals
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
NovoNordisk
Pfizer
Regeneron
Price
If you are a donor or speaker at this event, please email Ashley Hertrich ([email protected]) for your registration.
** Credit(s) must be claimed within 10 days after activity start date. Credit(s) will not be awarded after this date. **